Pipeline

Pipeline of Investigational Therapeutics

Developing a deep, sustainable pipeline of novel neurobehavioral therapeutics

We have built a growing pipeline of investigational therapeutics. We have internal discovery capabilities and expect to grow our pipeline both organically and through partnerships.

Program/Target
Indication
  • Discovery
  • Preclinical
  • Phase 1
  • Phase 2
  • Phase 3
Phase
Major Depressive Disorder
Phase 2
Parkinson’s Disease
Phase 2
Anxiety Disorders
Phase 1
Early Discovery
Multiple
Discovery